Lonza Launches New GS Gene Expression System

Lonza says it has launched the new GS Xceed gene expression system—the latest generation of Lonza’s GS System, which has been used to create more than 100 cell lines and 13 therapeutic drugs currently on the market. GS Xceed has been shown to reduce cell line development timelines by up to 6 weeks over the existing CHOK1SV-based system and has achieved titers of up to 6 g/L, Lonza says. Both emerging and established companies with protein therapeutics in their pipeline can access the new system by either a research evaluation agreement or a commercial...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers